TokenPost·
Abbott Lowers 2026 Comparable Sales-Growth Outlook to About 6%
6%
2026 sales growth
The planned spin-off would distribute shares to Abbott shareholders, with a close targeted by the end of 2027 pending approvals, an effective Form 10 registration statement and final board approval.